135 related articles for article (PubMed ID: 12434715)
1. Antisense drugs progressing through product pipelines.
Traynor K
Am J Health Syst Pharm; 2002 Nov; 59(21):2046-7. PubMed ID: 12434715
[No Abstract] [Full Text] [Related]
2. New CMV retinitis drug approved.
Body Posit; 1998 Oct; 11(10):10. PubMed ID: 11365907
[TBL] [Abstract][Full Text] [Related]
3. Fomivirsen approved for CMV retinitis.
Roehr B
J Int Assoc Physicians AIDS Care; 1998 Oct; 4(10):14-6. PubMed ID: 11365956
[TBL] [Abstract][Full Text] [Related]
4. Fomivirsen approved for CMV retinitis: first antisense drug.
AIDS Treat News; 1998 Sep; (302):7. PubMed ID: 11365764
[TBL] [Abstract][Full Text] [Related]
5. Vitravene--another piece in the mosaic.
Crooke ST
Antisense Nucleic Acid Drug Dev; 1998 Aug; 8(4):vii-viii. PubMed ID: 9743463
[No Abstract] [Full Text] [Related]
6. Fomiversen sodium approved to treat CMV retinitis.
Piascik P
J Am Pharm Assoc (Wash); 1999; 39(1):84-5. PubMed ID: 9990192
[No Abstract] [Full Text] [Related]
7. Shutting down a gene. Antisense drug wins approval.
Stix G
Sci Am; 1998 Nov; 279(5):46, 50. PubMed ID: 9841380
[No Abstract] [Full Text] [Related]
8. Antisense drug closer to approval.
AIDS Patient Care STDS; 1998 Oct; 12(10):805-6. PubMed ID: 11362033
[No Abstract] [Full Text] [Related]
9. Technology evaluation: fomivirsen, Isis Pharmaceuticals Inc/CIBA vision.
Orr RM
Curr Opin Mol Ther; 2001 Jun; 3(3):288-94. PubMed ID: 11497353
[TBL] [Abstract][Full Text] [Related]
10. Fomivirsen approved.
AIDS Patient Care STDS; 1998 Dec; 12(12):943. PubMed ID: 11362071
[No Abstract] [Full Text] [Related]
11. First oligonucleotide in U.S. clinical trials for CMV retinitis.
AIDS Patient Care STDS; 1997 Jun; 11(3):198-9. PubMed ID: 11361805
[No Abstract] [Full Text] [Related]
12. FDA approves fomivirsen, famciclovir, and Thalidomide. Food and Drug Administration.
Highleyman L
BETA; 1998 Oct; ():5. PubMed ID: 11365993
[TBL] [Abstract][Full Text] [Related]
13. First "antisense" drug will treat CMV retinitis.
Marwick C
JAMA; 1998 Sep; 280(10):871. PubMed ID: 9739955
[No Abstract] [Full Text] [Related]
14. Sense antisense nonantisense. Can these novel antivirals knock HIV senseless?
Chang HE; Mascolini M
J Int Assoc Physicians AIDS Care; 1995 Feb; 1(1):11-8. PubMed ID: 11362229
[TBL] [Abstract][Full Text] [Related]
15. GEM 132. Gene expression modulation 132.
Drugs R D; 1999 Nov; 2(5):313-4. PubMed ID: 10728469
[No Abstract] [Full Text] [Related]
16. Oral prodrug of ganciclovir approved for CMV retinitis.
Am J Health Syst Pharm; 2001 Jun; 58(11):946, 948. PubMed ID: 11402485
[No Abstract] [Full Text] [Related]
17. Genasense: it ain't over till the fat lady sings.
Stein CA
Oligonucleotides; 2007; 17(4):345-8. PubMed ID: 17949263
[No Abstract] [Full Text] [Related]
18. FDA grants marketing clearance of Vistide for the treatment of CMV retinitis.
AIDS Patient Care STDS; 1996 Dec; 10(6):383-4. PubMed ID: 11361576
[No Abstract] [Full Text] [Related]
19. FDA panel unanimously recommends approval of Vistide for CMV retinitis. Food and Drug Administration.
J Int Assoc Physicians AIDS Care; 1996 May; 2(5):50. PubMed ID: 11363532
[TBL] [Abstract][Full Text] [Related]
20. ICAAC: what else is new?
Prescott LM
Posit Aware; 1996; 7(1):10-1. PubMed ID: 11363114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
